Manuel Lasalle

Manuel Lasalle is a scientist specializing in bioconjugation at Zymeworks Inc. since February 2017, following a tenure as an associate scientist in medicinal chemistry. Prior experience includes a postdoctoral fellowship at Simon Fraser University, focusing on the development of bone-targeting compounds, as well as a PhD position at INSERM, where research concentrated on designing and synthesizing topical intestinal GPCR agonists. Manuel's academic background encompasses a Doctor of Philosophy in Medicinal Chemistry and a Doctor of Pharmacy from the University of Lille 1 Sciences and Technology, supplemented by a Master 2 recherche in Chemistry and Biology. Early career roles involved internships and volunteer positions at VIB and INSERM, emphasizing medicinal chemistry and target validation.